Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. 1978

M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel

Cis-dichlorodiammineplatinum (II) (cisDDP) has been extensively studied as an antitumour agent; its binding to DNA has been proved but the radiosensitizing action has scarcely been tested. We report here that on TC.SV -40 mammalian cells cisDPP acts as a dose-modifying factor for ionizing radiation. The radiosensitizing action can be induced by two different mechanisms: reaction with non protein-SH groups and inhibition of repair processes. The cisDDP-DNA complex was studied against increasing radiation doses by analytical centrifugation and by spectrophotometrical measurements. The native complex seems to be more radiation resistant than the denatured one.

UI MeSH Term Description Entries
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response

Related Publications

M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
January 1979, Cancer treatment reports,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
July 1978, Arizona medicine,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
January 1979, Cancer treatment reports,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
January 1979, Cancer treatment reports,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
January 1983, Journal of cancer research and clinical oncology,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
April 1979, Cancer treatment reports,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
January 1987, European journal of drug metabolism and pharmacokinetics,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
August 1988, Journal of cell science,
M V Alvarez, and G Cobreros, and A Heras, and M C Lopez Zumel
July 1976, Cancer treatment reports,
Copied contents to your clipboard!